Effects of acute and chronic arecoline in adult zebrafish: Anxiolytic-like activity, elevated brain monoamines and the potential role of microglia
|
10.01.2021 |
Serikuly N.
Alpyshov E.T.
Wang D.M.
Wang J.T.
Yang L.E.
Hu G.J.
Yan D.N.
Demin K.A.
Kolesnikova T.O.
Galstyan D.
Amstislavskaya T.G.
Babashev A.M.
Mor M.S.
Efimova E.V.
Gainetdinov R.R.
Strekalova T.
de Abreu M.S.
Song C.
Kalueff A.V.
|
Progress in Neuro-Psychopharmacology and Biological Psychiatry |
10.1016/j.pnpbp.2020.109977 |
0 |
Ссылка
© 2020 Elsevier Inc. Arecoline is a naturally occurring psychoactive alkaloid with partial agonism at nicotinic and muscarinic acetylcholine receptors. Arecoline consumption is widespread, making it the fourth (after alcohol, nicotine and caffeine) most used substance by humans. However, the mechanisms of acute and chronic action of arecoline in-vivo remain poorly understood. Animal models are a valuable tool for CNS disease modeling and drug screening. Complementing rodent studies, the zebrafish (Danio rerio) emerges as a promising novel model organism for neuroscience research. Here, we assessed the effects of acute and chronic arecoline on adult zebrafish behavior and physiology. Overall, acute and chronic arecoline treatments produced overt anxiolytic-like behavior (without affecting general locomotor activity and whole-body cortisol levels), with similar effects also caused by areca nut water extracts. Acute arecoline at 10 mg/L disrupted shoaling, increased social preference, elevated brain norepinephrine and serotonin levels and reduced serotonin turnover. Acute arecoline also upregulated early protooncogenes c-fos and c-jun in the brain, whereas chronic treatment with 1 mg/L elevated brain expression of microglia-specific biomarker genes egr2 and ym1 (thus, implicating microglial mechanisms in potential effects of long-term arecoline use). Finally, acute 2-h discontinuation of chronic arecoline treatment evoked withdrawal-like anxiogenic behavior in zebrafish. In general, these findings support high sensitivity of zebrafish screens to arecoline and related compounds, and reinforce the growing utility of zebrafish for probing molecular mechanisms of CNS drugs. Our study also suggests that novel anxiolytic drugs can eventually be developed based on arecoline-like molecules, whose integrative mechanisms of CNS action may involve monoaminergic and neuro-immune modulation.
Читать
тезис
|
Decoding the role of zebrafish neuroglia in CNS disease modeling
|
01.01.2021 |
Zabegalov K.N.
Wang D.
Yang L.E.
Wang J.
Hu G.
Serikuly N.
Alpyshov E.T.
Khatsko S.L.
Zhdanov A.
Demin K.A.
Galstyan D.S.
Volgin A.D.
de Abreu M.S.
Strekalova T.
Song C.
Amstislavskaya T.G.
Sysoev Y.
Musienko P.E.
Kalueff A.V.
|
Brain Research Bulletin |
10.1016/j.brainresbull.2020.09.020 |
0 |
Ссылка
© 2020 Elsevier Inc. Neuroglia, including microglia and astrocytes, is a critical component of the central nervous system (CNS) that interacts with neurons to modulate brain activity, development, metabolism and signaling pathways. Thus, a better understanding of the role of neuroglia in the brain is critical. Complementing clinical and rodent data, the zebrafish (Danio rerio) is rapidly becoming an important model organism to probe the role of neuroglia in brain disorders. With high genetic and physiological similarity to humans and rodents, zebrafish possess some common (shared), as well as some specific molecular biomarkers and features of neuroglia development and functioning. Studying these common and zebrafish-specific aspects of neuroglia may generate important insights into key brain mechanisms, including neurodevelopmental, neurodegenerative, neuroregenerative and neurological processes. Here, we discuss the biology of neuroglia in humans, rodents and fish, its role in various CNS functions, and further directions of translational research into the role of neuroglia in CNS disorders using zebrafish models.
Читать
тезис
|
Classification (Agonist/antagonist) and regression “structure-activity” models of drug interaction with 5-HT6
|
01.01.2018 |
Raevsky O.
Grigorev V.
Yarkov A.
Polianczyk D.
Tarasov V.
Bovina E.
Bryzhakina E.
Dearden J.
Avila-Rodriguez M.
Aliev G.
|
Central Nervous System Agents in Medicinal Chemistry |
|
0 |
Ссылка
© 2018 Bentham Science Publishers. Introduction: One promising target for novel psychotropic drugs is the 5-HT6 receptor, G-Protein-Coupled Receptor (GPCR) family, displaying seven transmembrane domains. There is considerable interest in how both 5-HT6 receptor agonist and antagonist compounds can have marked procognitive effects. Methods: An exact structure of the 5-HT6 receptor is not available, so application of powerful methods of (Q)SAR and molecular modelling, which play an essential role in modern drug design, are currently limited to structure-based homology models. The present study is devoted to a detailed QSAR analysis of 61 drugs (26 agonists and 35 antagonists) acting on the 5-HT6 receptor (rattus norvegicus and homo sapiens). Five classification methods were used: k-Nearest Neighbors (k-NN), Logistic Regression (LG), Linear Discriminant Analysis (LDA), Random Forest (RF), and Support Vector Machine (SVM). Multiple Regression Analysis (MRA) was involved also for regression analysis. Spectra of Inter Atomic Interactions (SIAI) were applied in the search for ligand centres interacting with the 5-HT6 receptor. Results & Conclusion: SAR and QSAR models based on the use of HYBOT, MOLTRA, VolSurf+, and SYBYL programs, and having cross-validated coefficients of determination of at least 0.80, show a predominant influence of H-bond acceptor ability and hydrophobicity on the type of ligand activity and degree of inhibition.
Читать
тезис
|